期刊文献+

激光点灼治疗带状疱疹的效果 被引量:2

THE USAGE OF LASER DOTTING BURNING IN THE TREATMENT OF HERPES ZOSTER
下载PDF
导出
摘要 目的探讨激光点灼治疗带状疱疹的效果。方法急性带状疱疹病人62例,随机分为2组。A组32例,给予激光点灼+阿昔洛韦治疗;B组30例,给予阿昔洛韦+可由软膏治疗。比较两组疼痛减轻时间、皮疹结痂时间、痊愈时间及有无遗留带状疱疹后神经痛。结果A组疼痛减轻时间、结痂时间及痊愈时间较B组明显缩短(t′=284.0、265.2、165.4,P<0.01),无遗留神经痛。结论激光点灼治疗带状疱疹安全,操作简单,无副作用,可明显缩短疗程。 Objective To assess the efficacy of laser dotting coagulation in the treatment of herpes zoster. Methods Sixty two cases were randomly divided into two groups: group A (32 cases) received laser therapy plus acyclovir; group B, acyclovir plus ointment. The time of improvement of clinical symptoms was observed. Results The time of pain relieved, dry-up of blisters and completely cured in groupAwassignificantlyshorterthanthatingroupB(t'=284.0, 265.2,165.4;P〈0.01). There was no postherpetic neuralgia in group A. Conclusion Laser photocoagulation is safe and simple for acute herpes zoster, which shortens the course of treatment without any obvious side effects.
出处 《齐鲁医学杂志》 2008年第4期353-354,共2页 Medical Journal of Qilu
关键词 疱疹.带状 激光凝固术 治疗结果 Herpes zoster Laser coagulation Treatment outcome
  • 相关文献

参考文献3

二级参考文献1

共引文献20

同被引文献12

  • 1LIN JT, MALLO O. Treatment of presbyopia by infrared la ser radial sclerectomy[J]. J Refract Surg , 2003,19(4):465- 746.
  • 2DWORKIN R H, O’CONNOR A B,AUDETTE J, et al.Recommendations for the pharmacological management ofneuropathic pain: an overview and literature update[J]. MayoClinic Proceedings Mayo Clinic, 2010,85(3 Suppl) :S3-14.
  • 3ATTAL N, CRUCCU G,BARON R,et al. EFNS guidelineson the pharmacological treatment of neuropathic pain: 2010revision [J]. European Journal of Neurology: the OfficialJournal of the European Federation of Neurological Societies,2010,17(9):1088-1113.
  • 4BRIL V,ENGLAND J,FRANKLIN G M, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: re-port of the American academy of neurology, the American as-sociation of neuromuscular and electrodiagnostic medicine,and the American academy of physical ition[J]. Neurology, 2011,3(4) :345-352.
  • 5POHL R B,FELTNER D E, FIEVE R R,et al. Efficacy ofpregabalin in the treatment of generalized anxiety disorder:double-blind,placebo-controlled comparison of BID versusTID dosing [J]. Journal of Clinical Psychopharmacology?2005,25(2):151-158.
  • 6FELTNER D E, CROCKATT J G, DUBOVSKY S J, et al.A randomized, double-blind, placebo-controlled? fixed-dose,muJticenter study of pregabalin in patients with generalizedanxiety disorder[J]. Journal of Clinical Psychopharmacology?2003,23(3):240-249.
  • 7KRUSZEWSKI S P, SHANE J A. Pregabalin in central neu-ropathic pain associated with spinal cord injury: a placebo-con-trolled trial[J]. Neurology, 2007 ,68(24) :2158-2159.
  • 8VRANKEN J H, DIJKGRAAF M G, KRUIS M R, et al.Pregabalin in patients with centraldomized,double-blind,placebo-controlleddose regimen[j]. Pain,2008,136( 1/2) : 150-157.
  • 9BANNISTER K,SIKANDAR S, BAUER C S, et al. Prega-balin suppresses spinal neuronal hyperexcitability and visceralhypersensitivity in the absence of peripheral pathophysiology[J]. Anesthesiology,2011,115(1) : 144-152.
  • 10KUMAR N,LAFERRIERE A,YU J S, et al. Evidence thatpregabalin reduces neuropathic pain by inhibiting the spinal re-lease of glutamate[J]. Journal of Neurochemistry, 2010,113?2):552-561.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部